ReviewPathology oncology research : POR2024

Advancing neoadjuvant therapies in resectable non-small cell lung cancer: implications for novel treatment strategies and biomarker discovery.

Hyein Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.